Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLUE | GNFT | CDXC | ||
| Company | Monte Rosa Therapeutics Inc | Genfit S.A. ADR | Chromadex Corp CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.83 | 4.15 | 2.49 | ||
| High | 3.90 | 4.21 | 2.55 | ||
| Low | 3.61 | 4.11 | 2.44 | ||
| Last | 3.69 | 4.15 | 2.52 | ||
| Change | -0.20 | +0.18 | -0.02 | ||
| % Change | -5.14% | +4.53% | -0.79% | ||
| Volume | 289,577 | 3,184 | 155,940 | ||
| 20-Day Average Volume | 264,058 | 33,314 | 640,347 | ||
| Previous Close | 3.89 | 3.97 | 2.54 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.82 | 4.30 | 2.80 | ||
| 20-Day Raw Stochastic | 34.38% | 26.80% | 16.46% | ||
| 20-Day Relative Strength | 42.01% | 49.46% | 39.96% | ||
| Weighted Alpha | -44.55 | +19.35 | +4.18 | ||
| Today's Opinion | 88% Sell | 56% Buy | 8% Buy | ||
| Previous Opinion | 72% Sell | 56% Buy | 8% Buy | ||
| Last Month's Opinion | 56% Sell | 100% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.99% since 06/27/24 | +8.03% since 06/27/24 | -5.66% since 06/27/24 | ||
| Low | 3.21 on 06/28/24 | 3.61 on 06/28/24 | 2.44 on 07/05/24 | ||
| High | 4.19 on 07/01/24 | 4.21 on 07/05/24 | 2.80 on 06/28/24 | ||
| 1-Month | |||||
| %Chg | -10.76% since 06/05/24 | -21.62% since 06/05/24 | -12.59% since 06/05/24 | ||
| Low | 3.21 on 06/28/24 | 3.61 on 06/28/24 | 2.31 on 06/26/24 | ||
| High | 4.49 on 06/12/24 | 5.70 on 06/10/24 | 3.49 on 06/07/24 | ||
| 3-Month | |||||
| %Chg | -48.37% since 04/05/24 | +18.19% since 04/05/24 | -37.81% since 04/05/24 | ||
| Low | 3.21 on 06/28/24 | 3.40 on 05/01/24 | 2.31 on 06/26/24 | ||
| High | 8.22 on 04/09/24 | 6.05 on 05/30/24 | 4.36 on 04/08/24 | ||
| 6-Month | |||||
| %Chg | -33.94% since 01/05/24 | +8.03% since 01/05/24 | +71.23% since 01/05/24 | ||
| Low | 3.21 on 06/28/24 | 3.31 on 01/17/24 | 1.36 on 01/23/24 | ||
| High | 8.84 on 03/26/24 | 6.05 on 05/30/24 | 4.65 on 04/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 196,492 | 197,952 | 191,869 | ||
| Shares Outstanding, K | 50,512 | 49,862 | 75,539 | ||
| Annual Sales | 0 | 41,320,000 | 83,570,000 | ||
| Annual Net Income | -135,350,000 | -31,270,000 | -4,940,000 | ||
| Last Quarter Sales | 1,060,000 | 14,265,000 | 22,150,000 | ||
| Last Quarter Net Income | -31,970,000 | N/A | -490,000 | ||
| 60-Month Beta | 1.38 | 1.22 | 1.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.53 on 05/09/24 | N/A | -0.01 on 05/08/24 | ||
| Latest Earnings Date | 08/08/24 | 07/04/24 | 08/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||